1.0
Jun 24, 2021
Current employee, more than 3 years
Plymouth Meeting, PA
Recommend
CEO approval
Business outlook
Pros
Great co-workers who care about good science.
Cons
Poor executive and scientific leadership has squandered the company's position as an industry leader in COVID vaccine research. Significant numbers of people jumping ship every month - legal and clinical operations department cannot keep up with the losses.